Decision conflict before cancer surgery correlates with lower activity after surgery

October 29, 2020

BOSTON - Nearly one-third of cancer patients who decide to undergo surgery for their condition may have second thoughts, and this decision conflict may lead to less favorable treatment outcomes in both the near- and long-term, according to a team of investigators at Massachusetts General Hospital (MGH) and Ariadne Labs, a joint center for health systems innovation at the Harvard T.H. Chan School of Public Health and Brigham and Women's Hospital (BWH).

In a pilot study to see whether a survey and sensor data collected from a smartphone app could help identify clinically significant decision conflict in patients scheduled to undergo cancer surgery, Nikhil Panda, MD, MPH, from MGH and colleagues found that 27 percent reported having a conflict about their decision.

"When we followed that group out to 90 days after surgery, and even after accounting for potential differences between the group that reported conflict before surgery and the group that didn't, the people who said they had conflict were less active overall," Panda said. "In surgery, we know that if people are more active, it's an independent predictor of having better functional outcomes over the long term."

The findings are reported in the journal .

Patients with cancers that can be treated by surgery often wrestle with issues such as their treatment goals (for example, the potential for cure or symptom relief) and their health-related quality of life following treatment.

Cancer specialists try their best to engage patients in decision making regarding their care, but as Panda and colleagues write, "the lack of scalable, generalizable, and patient-centered outcome measurement tools means that many patients face cancer treatment, including surgery, without an understanding of how the intervention will affect outcomes that matter the most to them."

That lack of understanding can lead to clinically significant decision conflict, which has been shown in previous studies to be associated with problems such as patients not following treatment plans, strained patient-provider relationships and poorer emotional and psychological health.

To get a better understanding of the effects of decision conflict on postoperative health, the investigators recruited patients who were scheduled for surgery within a week or so to treat cancers of the breast, skin, soft tissues, abdomen or thyroid/parathyroid, and who owned a smartphone running on the Apple iOS or Android operating systems.

The patients were asked to download a data-gathering application that delivered to their phones the Decision Conflict Scale, a certified tool for measuring clinically significant decision conflict. The app also used the phone's motion-sensing accelerometer to gather continual data about activity following surgery.

Of 85 patients who downloaded the app and completed the Decision Conflict Scale, 27 percent reported clinically significant decision conflict, and although this group did not differ in pre-operative physical activity from the patients who did not report decision conflict, Panda and colleagues found that at 30, 60, and 90 days after surgery the patients with decision conflict had significantly lower levels of physical activity.

"If we can find something that's easily modifiable to improve that outcome, that would be a good thing. Factors such as obesity and smoking are very difficult to modify in the short term, but we may be able to reduce conflict by better informed consent, using decision aids, or improving communication between patients and their surgeons. These are all low-hanging fruit," Panda said.
-end-
Co-authors of the paper are Ian Solsky MD, MPH, Montefiore Medical Center, Bronx; Christy E. Cauley, MD, MPH, MGH and BWH; Stuart Lipsitz, ScD, BWH; Eesha V Desai, BS, BWH; Emily J. Huang, PhD, Wake Forest University, Winston-Salem; Evan M. Benjamin, MD, MS, BWH; Carrie C. Lubitz, MD, MPH, MGH and BWH; Jukka-Pekka Onnela, DSc, BWH and Harvard T.H. Chan School of Public Health; and Alex B. Haynes, MD, MPH, BWH and Dell Medical School, University of Texas, Austin.

About the Massachusetts General Hospital

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The

Massachusetts General Hospital

Related Cancer Patients Articles from Brightsurf:

Higher risk of death in cancer patients with COVID-19 may be due to advanced age and more pre-existing conditions, rather than cancer itself
New research presented at this this week's ESCMID Conference on Coronavirus Diseases (ECCVID, online 23-25 September) suggests that the poor outcomes and higher death rates in cancer patients with COVID-19 could be due to them generally being older and having more underlying conditions, rather than due to the cancer itself.

The Lancet: Prostate cancer study finds molecular imaging could transform management of patients with aggressive cancer
Results from a randomised controlled trial involving 300 prostate cancer patients find that a molecular imaging technique is more accurate than conventional medical imaging and recommends the scans be introduced into routine clinical practice.

The art of cancer caregiving: How art therapies benefits those caring for cancer patients
A recent Drexel University study showed coloring and open-studio art therapy benefits stressed caregivers of cancer patients.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer tissue-freezing approach may help more breast cancer patients in lower income countries
A new reusable device created by the Johns Hopkins University can help women with breast cancer in lower income countries by using carbon dioxide, a widely available and affordable gas, to power a cancer tissue-freezing probe instead of industry-standard argon.

Lots of patients with cancer, cancer survivors use but don't report complementary/alternative medicine therapies
This study used data from a nationwide survey to estimate how many patients with cancer and cancer survivors use complementary and alternative medicines (CAMS) in addition to or instead of conventional therapies, and how many don't disclose that to their physicians.

Colorectal cancer in patients with early onset is distinct from that in older patients
New research indicates that colorectal cancer diagnosed at an early age has clinical and genetic features that are different from those seen in traditional colorectal cancer diagnosed later in life.

Comparable risk of recurrent venous thromboembolism between patients with unprovoked venous thromboembolism and patients with cancer
Patients with venous thromboembolism (VTE) carry a high risk of recurrence.

Personalized cancer vaccine may increase long-term survival in patients with deadly brain cancer
An international Phase III study led by researchers at UCLA has found that a personalized GBM vaccine may increase long-term survival in some patients.

Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation
A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.

Read More: Cancer Patients News and Cancer Patients Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.